@prefix c0x: <http://data.loterre.fr/ark:/67375/C0X> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix dc11: <http://purl.org/dc/elements/1.1/> .

c0x:-ZZB4PQ49-N
  dc:modified "2020-12-16"^^xsd:date ;
  skos:definition "CureVac N.V. is a biopharmaceutical company, legally domiciled in the Netherlands and headquartered in Tübingen, Germany, that develops therapies based on messenger RNA (mRNA). The company's focus is on developing vaccines for infectious diseases and drugs to treat for cancer and rare diseases. (Wikipédia)"@en, "CureVac est une société biopharmaceutique dont le siège social est à Tübingen, en Allemagne. Elle développe des thérapies basées sur l'ARN messager (ARNm). (Wikipédia)"@fr ;
  dc11:creator "Patricia Fener" ;
  dc:created "2020-12-15"^^xsd:date ;
  skos:exactMatch <https://en.wikipedia.org/wiki/CureVac>, <https://fr.wikipedia.org/wiki/CureVac> ;
  skos:prefLabel "Curevac"@en, "Curevac"@fr ;
  skos:altLabel "CureVac"@en ;
  a skos:Concept ;
  skos:broader c0x:-CBJ2JMB7-K ;
  skos:inScheme c0x: .

c0x: a skos:ConceptScheme .
c0x:-CBJ2JMB7-K
  skos:prefLabel "German pharmaceutical laboratory"@en, "laboratoire pharmaceutique allemand"@fr ;
  a skos:Concept ;
  skos:narrower c0x:-ZZB4PQ49-N .